⌘K
Loading ticker…
As of 2026-08-24, AIM ImmunoTech Inc. (AIM) has a 3-month relative strength percentile of 61 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 33. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 10.3%, relative volume 0.28×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
AIM is in a stage 4 downtrend, week 11. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -11.0% / -67.4%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
AIM is held by 2 ETFs as of May 2026. Top owner: AVDE at 0.00% weight, $11K notional.
Held by 2 ETFs · $15K across latest filings · largest weight 0.00% (AVSD).
Top 2 by value, from SEC N-PORT-P filings dated May 2026.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AIM Jan avg: 16.23% median: 1.92% win: 75% σ: 33.87% n: 4 2022-04-12 → 2026-07-31 | AIM Feb avg: -14.38% median: -12.23% win: 25% σ: 15.54% n: 4 2022-04-12 → 2026-07-31 | AIM Mar avg: -11.22% median: -13.38% win: 25% σ: 22.02% n: 4 2022-04-12 → 2026-07-31 | AIM Apr avg: -10.55% median: -13.26% win: 20% σ: 13.10% n: 5 2022-04-12 → 2026-07-31 | AIM May avg: -12.37% median: -12.37% win: 0% σ: 7.38% n: 4 2022-04-12 → 2026-07-31 | AIM Jun avg: 1803.64% median: 2.96% win: 60% σ: 4031.59% n: 5 2022-04-12 → 2026-07-31 | AIM Jul avg: -18.79% median: -7.16% win: 0% σ: 26.65% n: 5 2022-04-12 → 2026-07-31 | AIM Aug avg: -7.38% median: -6.75% win: 25% σ: 6.88% n: 4 2022-04-12 → 2026-07-31 (current) | AIM Sep avg: -12.24% median: -16.93% win: 25% σ: 17.12% n: 4 2022-04-12 → 2026-07-31 | AIM Oct avg: -6.88% median: -2.73% win: 25% σ: 11.18% n: 4 2022-04-12 → 2026-07-31 | AIM Nov avg: -16.57% median: -19.53% win: 25% σ: 14.73% n: 4 2022-04-12 → 2026-07-31 | AIM Dec avg: -17.25% median: -18.47% win: 0% σ: 8.80% n: 4 2022-04-12 → 2026-07-31 |